Clinical Trial Update: HOBOE: A Phase 3 Study of Adjuvant Triptorelin and Tamoxifen, Letrozole, or Letrozole and Zoledronic Acid in Premenopausal Patients With Breast Cancer. [Phase 3]

View source ↗

Summary

A Phase 3 trial update for HOBOE evaluating adjuvant triptorelin with tamoxifen, letrozole, or letrozole plus zoledronic acid in premenopausal breast cancer pat…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Letrozole (letrozole)
• Tamoxifen (tamoxifen)
• Triptorelin (triptorelin)
• Zoledronic acid (Zoledronic acid)

Snippet

Sponsor: National Cancer Institute, Naples | Conditions: Breast Cancer | Phase 3 | Status: UNKNOWN